Zasocitinib was 2.5 times more effective than deucravacitinib at helping patients with plaque psoriasis achieve completely clear skin, based on the first head-to-head test.

Three controlled trials evaluating different investigational treatments for hidradenitis suppurativa identify new targets capable of interrupting disease pathophysiology.

Real-world data show avelumab was an effective treatment for Merkel cell carcinoma in a retrospective study that included ...

Most prescriptions for specialty oral anticancer medications to treat blood cancers face initial insurer rejection, and even ...

CBL-514, an injectable drug that triggers fat cell death, significantly reduces visceral fat volume within just 4 weeks in a ...

A meta-analysis of over 11 million participants demonstrates that anxiety disorders and posttraumatic stress disorder may ...

As individuals with HIV live longer, clinicians face growing challenges involving comorbidities, care coordination, shared ...

Children hospitalized for RSV-B bronchiolitis before the age of 2 years report more severe wheezing and more frequent ...

New research digs deeper into what intense aerobic activity brings us on a cellular level. Should it alter your take-home ...

Semaglutide is linked to a reduced cardiovascular risk in patients with obesity and heart disease, but improvements in common ...

Clinicians can advise their older patients about the risks associated with RSV infection, but access to the vaccine is not ...

A 12-month course of dupilumab improves otologic and sinonasal outcomes in adults with severe nasal polyps and eosinophilic ...